BioXcel Therapeutics (BTAI) Receivables (2019 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Receivables of $216000.0 for Q1 2026, down 7.3% quarter-over-quarter from $233000.0 in Q4 2025.
BioXcel Therapeutics (BTAI) Receivables (2019 - 2026) Analysis & Trends
BioXcel Therapeutics' Receivables history runs 6 years deep, the most recent figure standing at $216000.0 for Q1 2026.
- In Q1 2026, Receivables changed N/A year-over-year to $216000.0; the TTM figure through Mar 2026 stood at $216000.0 (changed N/A YoY), while the FY2025 annual figure was $233000.0, up 77.86% from the prior year.
- Receivables for Q1 2026 stood at $216000.0, down from $233000.0 in the prior quarter.
- The five-year high for Receivables was $812000.0 in Q2 2024, with the low at $3000.0 in Q3 2024.
- The 5-year median for Receivables is $240500.0 (2022), against an average of $296500.0.
- Peak annual rise in Receivables reached 88.4% in 2024, while the deepest fall reached 99.59% in 2024.
- BioXcel Therapeutics' Receivables stood at $248000.0 in 2022, then sank by 71.37% to $71000.0 in 2023, then surged by 84.51% to $131000.0 in 2024, then jumped by 77.86% to $233000.0 in 2025, then declined by 7.3% to $216000.0 in 2026.
- Business Quant data shows BTAI's Receivables at $216000.0 in Q1 2026, $233000.0 in Q4 2025, and $17000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.08 Bn |
| 10 | BioXcel Therapeutics | 24.25 Mn | 24.25 Mn | 160,000.00 | 82,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 82,000.00 |
| Mar 31, 2026 | 216,000.00 |
| Dec 31, 2025 | 233,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Dec 31, 2024 | 131,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 812,000.00 |
| Mar 31, 2024 | 378,000.00 |
| Dec 31, 2023 | 71,000.00 |
| Sep 30, 2023 | 735,000.00 |
| Jun 30, 2023 | 431,000.00 |
| Mar 31, 2023 | 283,000.00 |
| Dec 31, 2022 | 248,000.00 |
| Dec 31, 2019 | 82,000.00 |
| Sep 30, 2019 | 173,000.00 |
| Jun 30, 2019 | 468,000.00 |
| Mar 31, 2019 | 291,000.00 |